Jaydess

Levonorgestrel, the active ingredient in Jaydess, is a progestogen presented as a 13.5 mg intrauterine system for intrauterine use. It prevents pregnancy by providing continuous hormonal contraception for women of reproductive age. GNH USA supplies Jaydess as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levonorgestrel in Jaydess acts within the hormonal contraceptive pathway to provide reliable, long‑acting pregnancy prevention. - Contraception: delivers a steady low dose of levonorgestrel to inhibit ovulation and thicken cervical mucus, preventing pregnancy for up to three years. - Post‑placental contraception: can be inserted immediately after delivery to give rapid onset of contraceptive protection.

Jaydess may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Irregular vaginal bleeding or spotting - Amenorrhea (absence of periods) - Headache - Breast tenderness - Acne or skin changes - Abdominal or pelvic pain

Serious or Rare Side Effects: - Uterine perforation during insertion - Expulsion or displacement of the device - Pelvic inflammatory disease or severe infection - Ectopic pregnancy if contraception fails - Allergic reaction to the device material - Severe hormonal thrombotic events (very rare)

Before insertion and during use, certain precautions should be observed to ensure safety and effectiveness. - Assess uterine cavity: confirm appropriate size and shape via ultrasound. - Contraindications: avoid in active pelvic infection, known or suspected pregnancy, or uterine anomalies. - Breast cancer: do not use in women with current or past estrogen‑dependent breast cancer. - Follow‑up: schedule regular examinations to check device position and address any symptoms. - Interact with other hormonal methods: concurrent use is unnecessary and may increase side‑effect risk. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Levonorgestrel released from Jaydess can be affected by other medicines that alter hormone metabolism.

Major Interactions (Avoid): - Rifampicin and other strong enzyme inducers (e.g., carbamazepine, phenytoin) – may reduce contraceptive efficacy. - St. John's wort – can increase hepatic metabolism of levonorgestrel. - Antiepileptic enzyme‑inducing drugs – may lower hormone levels. - Certain antiretroviral agents that induce CYP enzymes – may compromise protection. - High‑dose hormonal therapies – may interfere with device hormone release.

Moderate Interactions (Monitor Closely): - Ketoconazole and other azole antifungals – may increase levonorgestrel concentrations. - HIV protease inhibitors – can alter hormone levels, requiring clinical monitoring. - Certain antibiotics (e.g., griseofulvin) – may modestly reduce effectiveness. - Herbal supplements with unknown enzyme effects – advise caution and review.